Impact of fractionated stereotactic radiotherapy on activity of daily living and performance status in progressive/recurrent glioblastoma: a retrospective study.

Fiche publication

Date publication

décembre 2022

Journal

Radiation oncology (London, England)

Auteurs

Membres identifiés du Cancéropôle Est :
Pr TAILLANDIER Luc , Dr RECH Fabien , Dr DEMOGEOT Nadine

Tous les auteurs :
Demogeot N, Salleron J, Rech F, Taillandier L, Royer P, Vogin G

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/36474245

Résumé

The prognosis of recurrent glioblastoma (GBM) is poor, with limited options of palliative localized or systemic treatments. Survival can be improved by a second localized treatment; however, it is not currently possible to identify which patients would benefit from this approach. This study aims to evaluate which factors lead to a lower Karnofsky performance status (KPS) score after fractionated stereotactic RT (fSRT).